Westpac Banking Corporation »

United Therapeutics Corporation shares owned by Westpac Banking Corporation

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Westpac Banking Corporation from 13F filings

Historical chart of Westpac Banking Corporation investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Westpac Banking Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Westpac Banking Corporation

Quarter filed Position value Share count Share price at filing
2012-03-31 $1.3M 27k 47.12

More positions owned by Westpac Banking Corporation

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
UnitedHealth (UNH)
Intuit (INTU)
JPMorgan Chase & Co. (JPM)
Netflix (NFLX)
Colgate-Palmolive Company (CL)
Equinix (EQIX)
Welltower Inc Com reit (WELL)

View all positions for Westpac Banking Corporation

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation